Consumers all over the world are demanding natural ingredients in the products they consume. Within the beverage industry, many manufacturers are responding by removing artificial colors but costs and stability issues can create barriers against this change. With the launch of the CapColors® Orange 057 WSS colorant, Chr. Hansen now offers a solution.

Food and beverage companies all over the world are tuning into the increased consumer demand for products with less chemical additives and the wine industry is no exception. Two years of large scale trials demonstrate that Chr. Hansen’s Lactobacillus plantarum Viniflora® NoVA™ can be used to reduce sulfur dioxide (SO2) and thereby simplify the production of non-sulfited red wines.

​Joint press release from Dairy Innovation Australia Ltd (DIAL) and Chr. Hansen A/S:
The Board of Dairy Innovation Australia Ltd (DIAL) is pleased to announce that they have entered into a contract to finalize the sale of the DIAL culture production unit and strain collection to Chr. Hansen Holding A/S (Denmark) and Chr. Hansen Pty Ltd (Australia), a wholly owned subsidiary.

Millions of people around the world suffer from a range of gastrointestinal symptoms. Results from one of the world’s largest clinical studies on probiotics now show that the probiotic strain named BB-12® can be part of the solution by improving bowel regularity.

In collaboration with University of Copenhagen, Department of Plant and Environmental Sciences (KU) and Technical University of Denmark, Department of Systems Biology (DTU), researchers from Chr. Hansen have succeeded in producing carmine by a modern fermentation process. The first of a series of patents that protects the technology has been published today.

Jesper Allentoft has been with Chr. Hansen since 1 January, 2006 and is now retiring early at the age of 60. Ditte Marstrand Wulf will start as Group Vice President, Stakeholder Relations on 1 August, 2015.

With the completion and publication of the world’s largest clinical study on the immune effect of probiotics in adults, Chr. Hansen has obtained results indicating that the probiotic strain named L. CASEI 431® can shorten the duration of common cold and influenza-like illness, lower the use of health care resources and reduce use of antibiotics.

Related material

​A study initiated by Chr. Hansen has shown that bifidobacteria and lactobacilli are present in breast milk from Chinese mothers, strengthening the case for adding clinically documented probiotics to infant formula, in order to improve nutrition.

Related material

The market for natural dietary supplements is booming and Chr. Hansen will present its growing portfolio of products at this year’s Vitafoods Europe, with focus on the ground-breaking technology LIFE GEL®, and the award-nominated product solution Mother’s 1st.